Samantha J. Cox
Cardiff, WLS, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Real-world outcomes of second-line carboplatin plus pemetrexed after first-line osimertinib in EGFR-mutant advanced NSCLC: An international multicentre cohort study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 22, 2025
Cost-effectiveness of DPYD genotyping prior to fluoropyrimidine-based treatment for colorectal cancer in Wales.
Journal: British journal of clinical pharmacology
Published: August 20, 2025
First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study.
Journal: JTO clinical and research reports
Published: July 12, 2024
Efficacy of carboplatin-etoposide rechallenge after first-line chemo-immunotherapy in ES-SCLC: an international multicentric analysis.
Journal: Therapeutic advances in medical oncology
Published: May 20, 2024
Implementing Genomic Testing for Lung Cancer Into Routine Clinical Practice - The Welsh Experience.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: June 13, 2022
Impact of deviations in target volume delineation - Time for a new RTQA approach?
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: January 21, 2019
The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 28, 2017
Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell Carcinomas.
Journal: Current oncology reports
Published: February 19, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026